1. TRPV1 Activation by Anandamide via a Unique Lipid Pathway
   Chanté Muller et al, 2021, Journal of Chemical Information and Modeling CrossRef
2. Targeting CB2 and TRPV1: Computational Approaches for the Identification of Dual Modulators
   Paula Morales et al, 2022, Frontiers in Molecular Biosciences CrossRef
3. Effects of Cannabinoid Type 2 Receptor Agonist AM1241 on Morphine-Induced Antinociception, Acute and Chronic Tolerance, and Dependence in Mice
   Mingyue Zhang et al, 2018, The Journal of Pain CrossRef
4. The effect of cannabinoid type 2 receptor agonist on morphine tolerance
   Di Cui et al, 2024, IBRO Neuroscience Reports CrossRef
5. Cannabinoid Receptor Type 2 Agonist Reduces Morphine Tolerance via Mitogen Activated Protein Kinase Phosphatase Induction and Mitogen Activated Protein Kinase Dephosphorylation
   Qingling Kong et al, 2022, Neuroscience CrossRef
6. Opioid-sparing effect of cannabinoids for analgesia: an updated systematic review and meta-analysis of preclinical and clinical studies
   Suzanne Nielsen et al, 2022, Neuropsychopharmacology CrossRef
7. Endogenous opiates and behavior: 2017
   Richard J. Bodnar, 2020, Peptides CrossRef
8. Participation of transient receptor potential vanilloid 1 in paclitaxel-induced acute visceral and peripheral nociception in rodents
   Mateus Fortes Rossato et al, 2018, European Journal of Pharmacology CrossRef
9. The Role of the Cannabinoid System in Opioid Analgesia and Tolerance
   Ercan Ozdemir, 2020, Mini-Reviews in Medicinal Chemistry CrossRef
10. Cannabidiol enhances the antinociceptive effects of morphine and attenuates opioid-induced tolerance in the chronic constriction injury model
    Carlos Henrique Alves Jesus et al, 2022, Behavioural Brain Research CrossRef
11. Profiling of how nociceptor neurons detect danger – new and old foes
    T. Crosson et al, 2019, Journal of Internal Medicine CrossRef
12. Update on cannabis and cannabinoids for cancer pain
    Matthew Chung et al, 2020, Current Opinion in Anaesthesiology CrossRef